[1] Slots J. Periodontitis: facts, fallacies and the future[J]. Periodontology 2000, 2017,75(1):7-23.
[2] Page R C, Kornman K S. The pathogenesis of human periodontitis: an introduction[J]. Periodontol 2000, 1997,14:9-11.
[3] Nissen L, Sgorbati B, Biavati B, et al. Lactobacillus salivarius and L. gasseri down-regulate Aggregatibacter actinomycetemcomitans exotoxins expression[J]. Ann Microbiol, 2014,64:611-617.
[4] Claffey N, Polyzois I, Ziaka P. An overview of nonsurgical and surgical therapy[J]. Periodontol 2000, 2004,36:35-44.
[5] Pihlstrom B L, Michalowicz B S, Johnson N W. Periodontal diseases[J]. Lancet, 2005,366(9499):1809-1820.
[6] Suvan J E. Effectiveness of mechanical nonsurgical pocket therapy[J]. Periodontol 2000, 2005,37:48-71.
[7] Cobb C M. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing[J]. J Clin Periodontol, 2002,29 Suppl 2:6-16.
[8] Pradeep K, Kuttappa M A, Prasana K R. Probiotics and oral health: an update[J]. SADJ, 2014,69(1):20-24.
[9] Berezow A B, Darveau R P. Microbial shift and periodontitis[J]. Periodontol 2000, 2011,55(1):36-47.
[10] Graziani F, Karapetsa D, Alonso B, et al. Nonsurgical and surgical treatment of periodontitis: how many options for one disease?[J]. Periodontology 2000, 2017,75(1):152-188.
[11] Cobb C M. Lasers and the treatment of periodontitis: the essence and the noise[J]. Periodontology 2000, 2017,75(1):205-295.
[12] Pineiro M, Asp N G, Reid G, et al. FAO Technical meeting on prebiotics[J]. J Clin Gastroenterol, 2008,42 Suppl 3 Pt 2:S156-S159.
[13] Hold G L, Smith M, Grange C, et al. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?[J]. World J Gastroenterol, 2014,20(5):1192-1210.
[14] Pandey K R, Naik S R, Vakil B V. Probiotics, prebiotics and synbiotics- a review[J]. J Food Sci Technol, 2015,52(12):7577-7587.
[15] Devine D A, Marsh P D. Prospects for the development of probiotics and prebiotics for oral applications[J]. J Oral Microbiol, 2009,1.
[16] Staab B, Eick S, Knofler G, et al. The influence of a probiotic milk drink on the development of gingivitis: a pilot study[J]. J Clin Periodontol, 2009,36(10):850-856.
[17] Iniesta M, Herrera D, Montero E, et al. Probiotic effects of orally administered Lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial[J]. J Clin Periodontol, 2012,39(8):736-744.
[18] Tekce M, Ince G, Gursoy H, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study[J]. Journal of Clinical Periodontology, 2015,42(4):363-372.
[19] Piyush Shah M. Evaluation of the Effect of Probiotic (Inersan®) Alone, Combination of Probiotic with Doxycycline and Doxycycline Alone on Aggressive Periodontitis – A Clinical and Microbiological Study[J]. JOURNAL of CLINICAL AND DIAGNOSTIC RESEARCH, 2013.
[20] Teughels W, Newman M G, Coucke W, et al. Guiding periodontal pocket recolonization: a proof of concept[J]. J Dent Res, 2007,86(11):1078-1082.
[21] Maekawa T, Hajishengallis G. Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss[J]. J Periodontal Res, 2014,49(6):785-791.
[22] Nissen L, Sgorbati B, Biavati B, et al. Lactobacillus salivarius and L. gasseri down-regulate Aggregatibacter actinomycetemcomitans exotoxins expression[J]. Ann Microbiol, 2014,64:611-617.
[23] Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement[J]. Syst Rev, 2015,4:1.
[24] Shuster J J. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.[J]. Research Synthesis Methods, 2011,2(2):126-130.
[25] Tekce M, Ince G, Gursoy H, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study[J]. J Clin Periodontol, 2015,42(4):363-372.
[26] Ince G, Gursoy H, Ipci S D, et al. Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Chronic Periodontitis[J]. J Periodontol, 2015,86(6):746-754.
[27] Morales A, Carvajal P, Silva N, et al. Clinical Effects of Lactobacillus rhamnosus in Non-Surgical Treatment of Chronic Periodontitis: A Randomized Placebo-Controlled Trial With 1-Year Follow-Up[J]. J Periodontol, 2016,87(8):944-952.
[28] Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial[J]. J Oral Microbiol. 2010;2:10.3402/jom.v2i0.5344.
[29] Sajedinejad N, Paknejad M, Houshmand B, et al. Lactobacillus salivarius NK02: a Potent Probiotic for Clinical Application in Mouthwash[J]. Probiotics Antimicrob Proteins. 2018;10(3):485–495.
[30] Penala S, Kalakonda B, Pathakota K R, et al. Efficacy of local use of probiotics as an adjunct to scaling and root planing in chronic periodontitis and halitosis: A randomized controlled trial[J]. J Res Pharm Pract, 2016,5(2):86-93.
[31] Teughels W, Durukan A, Ozcelik O, et al. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study[J]. J Clin Periodontol, 2013,40(11):1025-1035.
[32] Laleman I, Yilmaz E, Ozcelik O, et al. The effect of a streptococci containing probiotic in periodontal therapy: a randomized controlled trial[J]. J Clin Periodontol, 2015,42(11):1032-1041.
[33] Laleman I, Pauwels M, Quirynen M, Teughels W. A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial[J]. J Clin Periodontol. 2020;47(1):43–53.
[34] Invernici MM, Salvador SL, Silva PHF, et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: A randomized clinical trial[J]. J Clin Periodontol. 2018;45(10):1198–1210.
[35] Pelekos G, Ho SN, Acharya A, Leung WK, McGrath C. A double-blind, paralleled-arm, placebo-controlled and randomized clinical trial of the effectiveness of probiotics as an adjunct in periodontal care[J]. J Clin Periodontol. 2019;46(12):1217–1227.
[36] Cionca N, Giannopoulou C, Ugolotti G, et al. Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis[J]. J Periodontol, 2009,80(3):364-371.
[37] Lang N P, Tonetti M S. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT)[J]. Oral Health Prev Dent, 2003,1(1):7-16.
[38] Riccia D N, Bizzini F, Perilli M G, et al. Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease[J]. Oral Dis, 2007,13(4):376-385.
[39] Quirynen M, Teughels W, De Soete M, et al. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects[J]. Periodontol 2000, 2002,28:72-90.
[40] Feres M, Figueiredo L C, Soares G M, et al. Systemic antibiotics in the treatment of periodontitis[J]. Periodontol 2000, 2015,67(1):131-186.
[41] Renvert S, Wikstrom M, Dahlen G, et al. Effect of root debridement on the elimination of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis from periodontal pockets[J]. J Clin Periodontol, 1990,17(6):345-350.
[42] Takamatsu N, Yano K, He T, et al. Effect of initial periodontal therapy on the frequency of detecting Bacteroides forsythus, Porphyromonas gingivalis, and Actinobacillus actinomycetemcomitans[J]. J Periodontol, 1999,70(6):574-580.
[43] Burton J P, Chilcott C N, Tagg J R. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics[J]. Oral Dis, 2005,11 Suppl 1:29-31.
[44] Lehtoranta L, Pitkaranta A, Korpela R. Probiotics in respiratory virus infections[J]. Eur J Clin Microbiol Infect Dis, 2014,33(8):1289-1302.
[45] De Greef E, Vandenplas Y, Hauser B, et al. The use of probiotics in IBD and IBS[J]. Minerva Pediatr, 2014,66(5):491-500.
[46] Orel R, Kamhi T T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease[J]. World J Gastroenterol, 2014,20(33):11505-11524.
[47] Smiley CJ, Tracy SL, Abt E, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts[J]. J Am Dent Assoc. 2015;146(7):508–24.e5.
[48] Martin-Cabezas R, Davideau JL, Tenenbaum H, Huck O. Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis[J]. J Clin Periodontol.
[49] Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota?[J]. J Clin Periodontol, 2011,38 Suppl 11:159-177.
[50] Geier M S, Butler R N, Howarth G S. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics[J]. Int J Food Microbiol, 2007,115(1):1-11.
[51] İnce G, Gürsoy H, İpçi Ş D, et al. Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Chronic Periodontitis[J]. Journal of Periodontology, 2015,86(6):746-754.
[52] Dieleman L A, Goerres M S, Arends A, et al. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment[J]. Gut, 2003,52(3):370-376.
[53] Yan F, Polk D B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells[J]. J Biol Chem, 2002,277(52):50959-50965.
[54] Schaefer L, Auchtung T A, Hermans K E, et al. The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups[J]. Microbiology, 2010,156(Pt 6):1589-1599.
[55] Gupta G. Probiotics and periodontal health[J]. J Med Life, 2011,4(4):387-394.